Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest

Respiratory Research

Table 1 The clinical characteristics of EGFR TKI-sensitive and –-resistance lung adenocarcinoma patients

	Number of cases	EGFR TKI-sensitive	EGFR TKI-resistance	p Value
Age (years)
< 65	14	10	4	0.445
≥ 65	13	8	5
Gender
Male	10	5	5	0.162
Female	17	13	4
Smoking
No-smokers	20	14	6	0.622
Smokers	6	4	2
Tumor size
T1/T2	15	10	5	0.675
T3/T4	9	6	3
lymphatic metastasis
Absent	16	10	6	0.449
Present	11	8	3
Clinical stage
IV期	27	18	9

P value represents the probability from a Chi-square test for different number of EGFR TKI-sensitive and –-resistance cases

ISSN: 1465-993X